Literature DB >> 10231036

Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.

.   

Abstract

OBJECTIVE: To summarize the procedures and outcomes of assisted reproductive technology (ART) initiated in the United States in 1996.
DESIGN: Data were collected electronically using the Society for Assisted Reproductive Technology Clinical Outcome Reporting System software and submitted to the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. PARTICIPANT(S): Three hundred programs submitted data on procedures performed in 1996. Data were collected after November 1997 so that the outcome of all pregnancies established would be known. MAIN OUTCOME MEASURE(S): Procedural outcomes measured included clinical pregnancy, ectopic pregnancy, abortion, stillbirth, delivery, and congenital abnormality. RESULT(S): Programs reported initiating 65,863 cycles of ART treatment, including frozen embryo and donor oocyte cycles. Of these. 44,647 cycles initiated were in vitro fertilization (IVF) (with and without micromanipulation) with 26.0% deliveries per retrieval; 2,879 were cycles of gamete intrafallopian transfer (GIFT) with 29.0% deliveries per retrieval; 1,200 were cycles of zygote intrafallopian transfer (ZIFT) with 30.9% deliveries per retrieval. In addition to these cycles initiated in 1996, 9,610 frozen embryo transfer procedures were initiated with 16.8% deliveries per transfer, 3,768 donor oocyte cycles were initiated with an overall success of 39.1% deliveries per transfer, 1,096 cryopreserved embryo transfers from donated oocytes procedures with an overall success of 20.8% deliveries per transfer, and 688 ART treatment cycles using a host uterus were initiated with an overall success of 31.3% deliveries per embryo transfer. Also, 1,341 cycles were reported as combinations of more than one treatment type, 19 cycles as research, 311 as embryo banking, and 304 as other (unclassified) cycle types. As a result of all procedures, a total of 14,702 deliveries were reported resulting in 21,196 neonates. CONCLUSION(S): In 1996, there were more programs reporting ART treatment and a significant (11.3%) increase in reported cycles. In comparable cycle types, overall average success rates (deliveries per retrieval) exhibited an actual increase of 3.5% (this is an increase of 15.8% when compared to the success rate for 1995).

Entities:  

Mesh:

Year:  1999        PMID: 10231036     DOI: 10.1016/s0015-0282(99)00124-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system.

Authors:  R Boostanfar; J K Jain; C C Slater; D E Tourgeman; M M Francis; R J Paulson
Journal:  J Assist Reprod Genet       Date:  2001-10       Impact factor: 3.412

2.  Monozygotic twins and triplets in association with blastocyst transfer.

Authors:  John K Jain; Robert Boostanfar; Cristin C Slater; Mary M Francis; Richard J Paulson
Journal:  J Assist Reprod Genet       Date:  2004-04       Impact factor: 3.412

3.  Fertility treatment in the forty and older woman.

Authors:  A Auyeung; M E Klein; V S Ratts; R R Odem; D B Williams
Journal:  J Assist Reprod Genet       Date:  2001-12       Impact factor: 3.412

Review 4.  A step-wise approach to sperm retrieval in men with neurogenic anejaculation.

Authors:  Mikkel Fode; Dana A Ohl; Jens Sønksen
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

Review 5.  Male sexual dysfunction and infertility associated with neurological disorders.

Authors:  Mikkel Fode; Sheila Krogh-Jespersen; Nancy L Brackett; Dana A Ohl; Charles M Lynne; Jens Sønksen
Journal:  Asian J Androl       Date:  2011-12-05       Impact factor: 3.285

Review 6.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

7.  Longevity of donor serum.

Authors:  Jennifer E Graves; H Lee Higdon; Jane E Johnson; Dawn W Blackhurst; William R Boone
Journal:  J Assist Reprod Genet       Date:  2004-02       Impact factor: 3.412

8.  Administration of beta2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles.

Authors:  Osni L Pinheiro; Mario Cavagna; Ricardo L R Baruffi; Ana L Mauri; Claudia Petersen; José G Franco
Journal:  J Assist Reprod Genet       Date:  2003-12       Impact factor: 3.412

Review 9.  The role of varicocele repair in the new era of assisted reproductive technology.

Authors:  Marcello Cocuzza; Mariana Amora Cocuzza; Frances Monette Papa Bragais; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

10.  Perinatal Care in Canada.

Authors:  Beverley Chalmers; Shi Wu Wen
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.